Literature DB >> 27647308

A Novel Combination of Docosahexaenoic Acid, All-Trans Retinoic Acid, and 1, 25-Dihydroxyvitamin D3 Reduces T-Bet Gene Expression, Serum Interferon Gamma, and Clinical Scores but Promotes PPARγ Gene Expression in Experimental Autoimmune Encephalomyelitis.

Mohammad Reza Shiri-Shahsavar1, Abbas Mirshafiee2, Karim Parastouei3, Abbas Ebrahimi-Kalan4, Saeed Yekaninejad5, Farid Soleymani2, Reza Chahardoli3, Ramin Mazaheri Nezhad Fard6, Ali Akbar Saboor-Yaraghi7,8.   

Abstract

Vitamins are immunologically interesting due to their significant immunomodulatory activities. Experimental autoimmune encephalomyelitis (EAE) is one of the most commonly used experimental models for studying autoimmune disorder in multiple sclerosis (MS). The aim of this study was to evaluate the protective and ameliorative effects of novel combination of all-trans retinoic acid (ATRA), 1,25-dihydroxyvitamin D3 (D3), and docosahexaenoic acid (DHA) on EAE-specific determinants and target gene expressions. Mice were randomly categorized into three groups before EAE induction [non-treated EAE (Group E), treated EAE (Group T), and healthy mice (Group H)]. Encephalomyelitis was induced in female C57BL/6 mice by subcutaneous immunization using commercial kits. Preceding day of EAE induction, combination of ATRA, D3, and DHA was administered with a single IP injection every 48 h and continued until day 26. Findings of present study showed that administration of vitamins A, D, and DHA significantly decreased average clinical scores, cumulative EAE score, and EAE incidence in Group T, compared to Group E (p values <0.001). Interferon γ secretion in serum and T-bet mRNA expression in splenocytes were significantly reduced (p = 0.004, p = 0.029, respectively) while PPARγ mRNA expression was significantly increased in Group T compared to Group E (p = 0.021). These findings highlighted that ATRA, D3, and DHA combination modulated PPARγ and T-bet gene expression and resulted in decrease in Th1 response and lymphocyte invasion into the central nervous system (CNS) and resultant inflammation. In conclusion, the results of this study suggested the potential use of this intervention in treatment and/or prevention of EAE/MS and probably other Th1 cell-mediated autoimmune diseases.

Entities:  

Keywords:  ATRA, D3 and DHA combination therapy; Experimental autoimmune encephalomyelitis (EAE); Multiple sclerosis (MS); Peroxisome proliferator-activated receptor gamma (PPARγ); T-bet; Vitamins

Mesh:

Substances:

Year:  2016        PMID: 27647308     DOI: 10.1007/s12031-016-0834-4

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  106 in total

Review 1.  Immunotherapeutic approaches in multiple sclerosis.

Authors:  Luciano Adorini
Journal:  J Neurol Sci       Date:  2004-08-15       Impact factor: 3.181

2.  Nuclear receptors, inflammation, and neurodegenerative diseases.

Authors:  Kaoru Saijo; Andrea Crotti; Christopher K Glass
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

3.  An interferon-gamma-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis.

Authors:  Santi Suryani; Ian Sutton
Journal:  J Neuroimmunol       Date:  2007-01-22       Impact factor: 3.478

Review 4.  The nuclear receptor PPARs as important regulators of T-cell functions and autoimmune diseases.

Authors:  Je-Min Choi; Alfred L M Bothwell
Journal:  Mol Cells       Date:  2012-02-28       Impact factor: 5.034

Review 5.  Vitamin A, infection, and immune function.

Authors:  C B Stephensen
Journal:  Annu Rev Nutr       Date:  2001       Impact factor: 11.848

Review 6.  Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-Analysis.

Authors:  Pouria Heydarpour; Shayan Khoshkish; Shabnam Abtahi; Maziar Moradi-Lakeh; Mohammad Ali Sahraian
Journal:  Neuroepidemiology       Date:  2015-06-16       Impact factor: 3.282

7.  Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation.

Authors:  Oliver Haworth; Manuela Cernadas; Rong Yang; Charles N Serhan; Bruce D Levy
Journal:  Nat Immunol       Date:  2008-06-22       Impact factor: 25.606

8.  PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells.

Authors:  Istvan Szatmari; Attila Pap; Ralph Rühl; Jiang-Xing Ma; Petr A Illarionov; Gurdyal S Besra; Eva Rajnavolgyi; Balazs Dezso; Laszlo Nagy
Journal:  J Exp Med       Date:  2006-09-18       Impact factor: 14.307

9.  Vitamin D3 influence the Th1/Th2 ratio in C57BL/6 induced model of experimental autoimmune encephalomyelitis.

Authors:  Maryam Soleimani; Seyed Behnamedin Jameie; Mehdi Mehdizadeh; Mahdieh Keradi; Masoumeh Masoumipoor; Soraya Mehrabi
Journal:  Iran J Basic Med Sci       Date:  2014-10       Impact factor: 2.699

10.  Comparison of Th1/Th2 cytokine profiles between primary and secondary haemophagocytic lymphohistiocytosis.

Authors:  Yuanyuan Chen; Zhujun Wang; Zebin Luo; Ning Zhao; Shilong Yang; Yongmin Tang
Journal:  Ital J Pediatr       Date:  2016-05-21       Impact factor: 2.638

View more
  1 in total

1.  Atorvastatin protects against postoperative neurocognitive disorder via a peroxisome proliferator-activated receptor-gamma signaling pathway in mice.

Authors:  Yinan Yang; Changwei Wei; Jinhu Liu; Danxu Ma; Chao Xiong; Dandan Lin; Anshi Wu
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.